R. Barentsen

1.1k total citations
22 papers, 871 citations indexed

About

R. Barentsen is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Reproductive Medicine. According to data from OpenAlex, R. Barentsen has authored 22 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Genetics and 7 papers in Reproductive Medicine. Recurrent topics in R. Barentsen's work include Menopause: Health Impacts and Treatments (15 papers), Estrogen and related hormone effects (7 papers) and Endometriosis Research and Treatment (7 papers). R. Barentsen is often cited by papers focused on Menopause: Health Impacts and Treatments (15 papers), Estrogen and related hormone effects (7 papers) and Endometriosis Research and Treatment (7 papers). R. Barentsen collaborates with scholars based in Netherlands, United States and Australia. R. Barentsen's co-authors include P. H. M. van de Weijer, D.J.M. van der Voort, Frans P.M.J. Groeneveld, Arno W. Hoes, A. C. Drogendijk, Frank C. den Boer, Jos A. M. Bramer, H. J. T. M. Haarman, Albert J. Feilzer and P. Patka and has published in prestigious journals such as Obstetrics and Gynecology, Osteoporosis International and Maturitas.

In The Last Decade

R. Barentsen

22 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Barentsen Netherlands 15 504 351 286 158 138 22 871
P. H. M. van de Weijer Netherlands 16 548 1.1× 402 1.1× 312 1.1× 159 1.0× 92 0.7× 30 875
Nimit Taechakraichana Thailand 16 193 0.4× 113 0.3× 147 0.5× 51 0.3× 124 0.9× 67 728
Joan Pitkin United Kingdom 15 220 0.4× 125 0.4× 89 0.3× 135 0.9× 201 1.5× 52 767
Ayman Ewies United Kingdom 17 178 0.4× 123 0.4× 94 0.3× 265 1.7× 153 1.1× 45 917
Sara De Vincentis Italy 11 125 0.2× 114 0.3× 45 0.2× 113 0.7× 49 0.4× 28 450
Pedro‐Antonio Regidor Germany 19 110 0.2× 65 0.2× 31 0.1× 433 2.7× 399 2.9× 69 936
Manee Rattanachaiyanont Thailand 18 98 0.2× 54 0.2× 41 0.1× 362 2.3× 274 2.0× 56 751
Paul G. Stumpf United States 15 134 0.3× 91 0.3× 20 0.1× 228 1.4× 142 1.0× 33 586
Gerald H. Holman United States 15 97 0.2× 136 0.4× 27 0.1× 36 0.2× 100 0.7× 31 619
İsa Özbey Türkiye 16 116 0.2× 48 0.1× 47 0.2× 197 1.2× 188 1.4× 58 852

Countries citing papers authored by R. Barentsen

Since Specialization
Citations

This map shows the geographic impact of R. Barentsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Barentsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Barentsen more than expected).

Fields of papers citing papers by R. Barentsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Barentsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Barentsen. The network helps show where R. Barentsen may publish in the future.

Co-authorship network of co-authors of R. Barentsen

This figure shows the co-authorship network connecting the top 25 collaborators of R. Barentsen. A scholar is included among the top collaborators of R. Barentsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Barentsen. R. Barentsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nachtigall, Lila E., Rod Baber, R. Barentsen, et al.. (2006). Complementary and Hormonal Therapy for Vasomotor Symptom Relief: A Conservative Clinical Approach. Journal of Obstetrics and Gynaecology Canada. 28(4). 279–289. 15 indexed citations
2.
Voort, D.J.M. van der, et al.. (2003). Early menopause: increased fracture risk at older age. Osteoporosis International. 14(6). 525–530. 139 indexed citations
3.
Barentsen, R., et al.. (2002). Hormone replacement therapy and surveillance considerations. Maturitas. 43. 57–67. 4 indexed citations
4.
Weijer, P. H. M. van de & R. Barentsen. (2002). Isoflavones from red clover (Promensil®) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas. 42(3). 187–193. 147 indexed citations
5.
Barentsen, R., et al.. (2001). Climacteric symptoms in a representative Dutch population sample as measured with the Greene Climacteric Scale. Maturitas. 38(2). 123–128. 74 indexed citations
6.
Weijer, P. H. M. van de, Piet C. Scholten, Marius J. van der Mooren, R. Barentsen, & Peter Kenemans. (1999). Bleeding patterns and endometrial histology during administration of low-dose estradiol sequentially combined with dydrogesterone. Climacteric. 2(2). 101–109. 15 indexed citations
7.
Stevenson, John S., Göran Samsioe, Amos Pines, et al.. (1998). Critical comments on the paper 'Randomized trial of estrogen plus progestin for secindary prevention of coronary heart disease in postmenopausal women.'. Maturitas. 31(1). 77–87. 3 indexed citations
8.
Weijer, P. H. M. van de, R. Barentsen, & Peter Kenemans. (1998). Women's expectations and acceptance of cyclic induced HRT bleeds. Maturitas. 30(3). 257–263. 13 indexed citations
9.
Boer, Frank C. den, Jos A. M. Bramer, P. Patka, et al.. (1998). Quantification of fracture healing with three-dimensional computed tomography. Archives of Orthopaedic and Trauma Surgery. 117(6-7). 345–350. 69 indexed citations
10.
Groeneveld, Frans P.M.J., et al.. (1998). Duration of hormonal replacement therapy in general practice; a follow-up study. Maturitas. 29(2). 125–131. 32 indexed citations
11.
Barentsen, R., et al.. (1997). Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 71(1). 73–80. 111 indexed citations
12.
Groeneveld, Frans P.M.J., et al.. (1996). Vasomotor symptoms and well-being in the climacteric years. Maturitas. 23(3). 293–299. 34 indexed citations
13.
Barentsen, R.. (1996). The climacteric in the Netherlands: a review of Dutch studies on epidemiology, attitudes and use of hormone replacement therapy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 64. S7–S11. 26 indexed citations
14.
Hingstman, L., et al.. (1994). [Needs assessment for gynecologists/obstetricians up to the year 2005].. PubMed. 138(19). 969–73. 1 indexed citations
15.
Groeneveld, Frans P.M.J., et al.. (1994). Determinants of first prescription of hormone replacement therapy. A follow-up study among 1689 women aged 45–60 years. Maturitas. 20(2-3). 81–89. 39 indexed citations
16.
Barentsen, R., et al.. (1994). The view of women aged 45–65 and their partners on aspects of the climacteric phase of life. European Journal of Obstetrics & Gynecology and Reproductive Biology. 57(2). 95–101. 19 indexed citations
17.
Groeneveld, Frans P.M.J., et al.. (1993). The climacteric and well-being. Journal of Psychosomatic Obstetrics & Gynecology. 14(2). 127–143. 24 indexed citations
18.
Groeneveld, Frans P.M.J., et al.. (1993). Relationships between attitude towards menopause, well-being and medical attention among women aged 45–60 years. Maturitas. 17(2). 77–88. 47 indexed citations
19.
Barentsen, R., et al.. (1993). Women's opinion on withdrawal bleeding with hormone replacement therapy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 51(3). 203–207. 42 indexed citations
20.
Wladimiroff, J. W., R. Barentsen, Henk C.S. Wallenburg, & A. C. Drogendijk. (1975). Fetal urine production in a case of diabetes associated with polyhydraminios.. PubMed. 46(1). 101–2. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026